Fortrea Belgium

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "David De Schacht",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "DSD Associates Audit \u0026 Advies BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De vergadering besluit unaniem om DSD Associates Audit \u0026 Advies BV, met maatschappelijke zetel te 3391 Meensel-Kiezegem, Kapellekensweg 57, vertegenwoordigd door de heer David De Schacht, bedrijfsrevisor, te herbenoemen voor een periode van 3 jaar."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "FORTREA BELGIUM",
    "legal_form": "BV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "FORTREA BELGIUM",
    "legal_form": "BV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "FORTREA BELGIUM",
    "legal_form": "BV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "FORTREA BELGIUM",
    "legal_form": "BV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Robert Pringle",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-06-15",
      "evidence_quote": "De aandeelhouders hebben besloten om de mandaten van de volgende personen als bestuurders van de vennootschap te be\u00EBindigen, met ingang vanaf 15 juni 2023: (i) de heer Robert Pringle en (ii) de heer Glenn Eisenberg."
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Glenn Eisenberg",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-06-15",
      "evidence_quote": "De aandeelhouders hebben besloten om de mandaten van de volgende personen als bestuurders van de vennootschap te be\u00EBindigen, met ingang vanaf 15 juni 2023: (i) de heer Robert Pringle en (ii) de heer Glenn Eisenberg."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "David Cooper",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-06-15",
      "evidence_quote": "De aandeelhouders hebben besloten om de volgende personen voor onbepaalde duur en met ingang vanaf 15 juni 2023 te benoemen als bestuurders van de vennootschap: (i) de heer David Cooper en (i) mevrouw Jill McConnell."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jill McConnell",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-06-15",
      "evidence_quote": "De aandeelhouders hebben besloten om de volgende personen voor onbepaalde duur en met ingang vanaf 15 juni 2023 te benoemen als bestuurders van de vennootschap: (i) de heer David Cooper en (i) mevrouw Jill McConnell."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "FORTREA BELGIUM",
    "legal_form": "BV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "FORTREA BELGIUM",
    "legal_form": "BV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "FORTREA BELGIUM",
    "legal_form": "BV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Robert Pringle",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-06-15",
      "evidence_quote": "De aandeelhouders hebben besloten om de mandaten van de volgende personen als bestuurders van de vennootschap te be\u00EBindigen, met ingang vanaf 15 juni 2023: (i) de heer Robert Pringle en (ii) de heer Glenn Eisenberg."
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Glenn Eisenberg",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-06-15",
      "evidence_quote": "De aandeelhouders hebben besloten om de mandaten van de volgende personen als bestuurders van de vennootschap te be\u00EBindigen, met ingang vanaf 15 juni 2023: (i) de heer Robert Pringle en (ii) de heer Glenn Eisenberg."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "David Cooper",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-06-15",
      "evidence_quote": "De aandeelhouders hebben besloten om de volgende personen voor onbepaalde duur en met ingang vanaf 15 juni 2023 te benoemen als bestuurders van de vennootschap: (i) de heer David Cooper en (ii) mevrouw Jill McConnell."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jill McConnell",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-06-15",
      "evidence_quote": "De aandeelhouders hebben besloten om de volgende personen voor onbepaalde duur en met ingang vanaf 15 juni 2023 te benoemen als bestuurders van de vennootschap: (i) de heer David Cooper en (ii) mevrouw Jill McConnell."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "FORTREA BELGIUM",
    "legal_form": "BV"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": true,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2023-05-01",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "LABCORP CLINICAL DEVELOPMENT",
    "legal_form": "BV"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "LABCORP CLINICAL DEVELOPMENT",
    "legal_form": "BV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "LABCORP CLINICAL DEVELOPMENT",
    "legal_form": "BV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "LABCORP CLINICAL DEVELOPMENT",
    "legal_form": "BV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "David De Schacht",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "DSD Associates Audit \u0026 Advies SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "l\u0027assembl\u00E9e des actionnaires d\u00E9cide, \u00E0 l\u0027unanimit\u00E9, de renouveler la nomination de la soci\u00E9t\u00E9 DSD Associates Audit \u0026 Advies SRL ayant son si\u00E8ge social \u00E0 3391 Meensel-Kiezegem, Kapellekensweg 57 et repr\u00E9sent\u00E9e par monsieur David De Schacht, r\u00E9viseur d\u0027entreprises, pour une p\u00E9riode de trois ans qui ex"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "LABCORP CLINICAL DEVELOPMENT",
    "legal_form": "SRL"
  }
}

{
  "stage": null,
  "notary": {
    "name": "Robert S. Pringle",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Brussel",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2021-12-30",
    "filing_date": "2021-12-23",
    "act_kind_objet": "Verklaring van de bestuurder in overeenstemming met arikel 2:54 van het"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2021-12-16",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "substantive_delegation",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0435.753.395",
        "name": "LABCORP CLINICAL DEVELOPMENT",
        "role": "other",
        "address": "Bourgetlaan 50 - 1130 Brussel",
        "is_foreign": false,
        "legal_form": "Besloten vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Philip Van Steenwinkel",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Sean Jonckheere",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Hogan Lovells International LLP",
        "role": "other",
        "address": "Wetenschapsstraat 23, 1040 Brussel",
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Ad-Ministerie BV",
        "role": "other",
        "address": "Brusselsesteenweg 66, 1860 Meise",
        "is_foreign": false,
        "legal_form": "BV",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "2:54"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "De verklaring betreft de woonplaatskeuze van de bestuurder van de vennootschap in overeenstemming met artikel 2:54 WVV. Geen overdracht van vermogen of rechtspositie.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "LABCORP CLINICAL DEVELOPMENT",
    "legal_form": "Besloten vennootschap"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Ad-Ministerie BV",
    "person_name": null,
    "org_rep_person_name": "Adriaan de Leeuw"
  },
  "summary_narrative": "De bestuurder van LABCORP CLINICAL DEVELOPMENT, Robert S. Pringle, verklaart op eer dat hij vanaf heden woonplaats wenst te kiezen op de zetel van de vennootschap, gelegen in Bourgetlaan 50, 1130 Brussel, in overeenstemming met artikel 2:54 van het Wetboek van Vennootschappen en Verenigingen. Hij verleent daarnaast een bijzondere volmacht aan Philip Van Steenwinkel, Sean Jonckheere en het advocatenkantoor Hogan Lovells International LLP, en aan Ad-Ministerie BV, vertegenwoordigd door Adriaan de Leeuw, om in zijn naam alle nodige handelingen uit te voeren bij het rechtspersonenregister, de onde",
  "co_filed_documents": [],
  "detected_real_type": "substantive_delegation",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": true,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2021-09-30",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "COVANCE CLINICAL AND PERIAPPROVAL SERVICES, AFGEKORT : COVANCE",
    "legal_form": "BVBA"
  },
  "signature_regime": "solo",
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Brussel",
        "region": "Brussels Gewest",
        "street": "Bourgetlaan",
        "country": "BE",
        "postcode": "1130",
        "box_number": null,
        "street_number": "50"
      },
      "old_address": {
        "city": "Sint-Lambrechts-Woluwe",
        "region": "Brussels Gewest",
        "street": "Marcel Thirylaan",
        "country": "BE",
        "postcode": "1200",
        "box_number": null,
        "street_number": "77"
      },
      "effective_date": "2021-09-30",
      "evidence_quote": "De raad van bestuur heeft besloten om de zetel van de vennootschap, met ingang vanaf 30 september 2021 te verplaatsen naar \u0022Bourgetlaan 50, 1130 Brussel (4de verdieping), Belgi\u00EB\u0022."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "COVANCE CLINICAL AND PERIAPPROVAL SERVICES, AFGEKORT : COVANCE",
    "legal_form": "BVBA"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "COVANCE CLINICAL AND PERIAPPROVAL SERVICES, AFGEKORT : COVANCE",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "COVANCE CLINICAL AND PERIAPPROVAL SERVICES, AFGEKORT : COVANCE",
    "legal_form": "NV"
  }
}

{
  "stage": "completed",
  "notary": {
    "name": "Fr\u00E9d\u00E9ric de GRAVE",
    "firm_city": null,
    "firm_name": "DEPUYT, RAES \u0026 de GRAVE, geassocieerde notarissen",
    "office_city": "Sint-Jans-Molenbeek",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2019-05-27",
    "filing_date": "2019-05-16",
    "act_kind_objet": "MET FUSIE DOOR OVERNEMING GELIJKGESTELDE VERRICHTING"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2019-05-01",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0435.753.395",
        "name": "Covance Clinical \u0026 Periapproval Services BVBA",
        "role": "acquiring",
        "address": "Marcel Thirylaan 77, 1200 Sint-Lambrechts-Woluwe",
        "is_foreign": false,
        "legal_form": "BVBA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Chiltern International BVBA",
        "role": "absorbed",
        "address": "Interleuvenlaan 15E bus 2.8, 3001 Leuven",
        "is_foreign": false,
        "legal_form": "BVBA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": "2019-01-01",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "De gehele patrimoine, inclusief actief en passief, van de over te nemen vennootschap Chiltern International BVBA wordt overgenomen door de overnemende vennootschap Covance Clinical \u0026 Periapproval Services BVBA.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2019-05-01"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "Covance Clinical \u0026 Periapproval Services",
    "legal_form": "BVBA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Fr\u00E9d\u00E9ric de GRAVE",
    "org_rep_person_name": null
  },
  "summary_narrative": "De buitengewone algemene vergadering van Covance Clinical \u0026 Periapproval Services BVBA heeft op 1 mei 2019 besloten tot de goedkeuring van een met fusie gelijkgestelde overname van Chiltern International BVBA. De overname is voltrokken zonder liquidatie van de overgenomen vennootschap, die vanaf 1 mei 2019 is ontbonden. De overnemende vennootschap had reeds alle aandelen van de over te nemen vennootschap in bezit, zodat er geen nieuwe aandelen zijn uitgegeven.",
  "co_filed_documents": [
    "uitgifte",
    "twee volmachten",
    "verzaking",
    "besluit zaakvoerder",
    "notulen dd 06/03/2019",
    "vertaling"
  ],
  "detected_real_type": "fusion_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 823350,
      "currency": "EUR",
      "after_eur": 1759560,
      "delta_eur": 823350,
      "before_eur": 936210,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2019-04-26",
      "evidence_quote": "het maatschappelijk kapitaal te verhogen met een bedrag van achthonderd drie\u00EBntwintigduizend driehonderdvijftig euro (EUR 823.350) om het te brengen van negenhonderd zesendertigduizend tweehonderd en tien euro (EUR 936.210) op \u00E9\u00E9n miljoen zevenhonderd negenenvijftigduizend vijfhonderdzestig euro (EUR 1.759.560) door een inbreng in natura",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "COVANCE CLINICAL AND PERIAPPROVAL SERVICES, AFGEKORT : COVANCE",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "COVANCE CLINICAL AND PERIAPPROVAL SERVICES, AFGEKORT : COVANCE",
    "legal_form": "NV"
  }
}

{
  "stage": "proposal",
  "notary": {
    "name": "Robert S. Pringle",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Brussel",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": null,
    "filing_date": "2019-03-19",
    "act_kind_objet": "Fusievoorstel"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2019-03-06",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0435.753.395",
        "name": "Covance Clinical \u0026 Periapproval Services",
        "role": "acquiring",
        "address": "Marcel Thirylaan 77, 1200 Sint-Lambrechts-Woluwe",
        "is_foreign": false,
        "legal_form": "BVBA",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0435.753.395",
        "name": "Chiltern International",
        "role": "absorbed",
        "address": "Technologielaan 13, 3001 Leuven",
        "is_foreign": false,
        "legal_form": "BVBA",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50",
      "719"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "De volledige activa en passiva van Chiltern International worden overgenomen door Covance Clinical \u0026 Periapproval Services. De verrichtingen van Chiltern worden boekhoudkundig geacht te zijn uitgevoerd voor rekening van Covance vanaf 1 januari 2019.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2019-01-01"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "Covance Clinical \u0026 Periapproval Services",
    "legal_form": "BVBA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Robert S. Pringle",
    "org_rep_person_name": null
  },
  "summary_narrative": "Op 6 maart 2019 hebben de bestuursorganen van Covance Clinical \u0026 Periapproval Services en Chiltern International een voorstel tot fusie door overneming opgesteld, waarbij Covance de overnemende vennootschap is en Chiltern de over te nemen vennootschap. Vanaf 1 januari 2019 worden de activa en passiva van Chiltern geacht te zijn overgenomen door Covance. Geen bijzondere voordelen worden toegekend aan bestuurders van de betrokken vennootschappen.",
  "co_filed_documents": [],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 188100,
      "currency": "EUR",
      "after_eur": 936210,
      "delta_eur": 188100,
      "before_eur": 748110,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2019-02-26",
      "evidence_quote": "het maatschappelijk kapitaal te verhogen met een bedrag van honderd achtentachtigduizend honderd euro (EUR 188.100) om het te brengen van zevenhonderd achtenveertigduizend honderd en tien euro (EUR 748.110) op negenhonderd zesendertigduizend tweehonderd en tien euro (EUR 936.210), door de inbreng in natura door LabCorp UK Holdings, Ltd.",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "COVANCE CLINICAL AND PERIAPPROVAL SERVICES, AFGEKORT : COVANCE",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "zaakvoerder",
      "person": {
        "rrn": null,
        "name": "Robert S. PRINGLE",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-02-12",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide que les personnes qui \u00E9taient jusqu\u0027\u00E0 ce jour les administrateurs de la soci\u00E9t\u00E9 sont \u00E0 pr\u00E9sent nomm\u00E9es comme g\u00E9rants non-statutaires de la soci\u00E9t\u00E9, et ce pour une dur\u00E9e ind\u00E9termin\u00E9e. Les g\u00E9rants sont d\u00E8s lors: -Monsieur Robert S. PRINGLE, domicili\u00E9 58 Arthur Road, RG40 2AG Wokingh"
    },
    {
      "kind": "director_in",
      "role": "zaakvoerder",
      "person": {
        "rrn": null,
        "name": "Glenn A. EISENBERG",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-02-12",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide que les personnes qui \u00E9taient jusqu\u0027\u00E0 ce jour les administrateurs de la soci\u00E9t\u00E9 sont \u00E0 pr\u00E9sent nomm\u00E9es comme g\u00E9rants non-statutaires de la soci\u00E9t\u00E9, et ce pour une dur\u00E9e ind\u00E9termin\u00E9e. Les g\u00E9rants sont d\u00E8s lors: ... -Monsieur Glenn A. EISENBERG, domicili\u00E9 9850 Heydon Hall Circle, Ch"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "COVANCE CLINICAL AND PERIAPPROVAL SERVICES, EN ABREGE : COVANCE CAPS",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2019-02-12",
    "legal_form_change": true
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "COVANCE CLINICAL AND PERIAPPROVAL SERVICES, AFGEKORT : COVANCE",
    "legal_form": "NV"
  },
  "signature_regime": "solo",
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "COVANCE CLINICAL AND PERIAPPROVAL SERVICES, EN ABREGE : COVANCE CAPS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Robert Pringle",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2017-06-30",
      "evidence_quote": "Par vote sp\u00E9cial et \u00E0 l\u0027unanimit\u00E9 l\u0027Assembl\u00E9e G\u00E9n\u00E9rale a d\u00E9cid\u00E9 de renouveler le mandat de Monsieur Robert Pringle, Arthur Road 58 \u00E0 GB-RG40 2AG Wokingham, Berkshire, England pour une p\u00E9riode de six ans \u00E0 partir du 30/06/2017."
    },
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "David De Schacht",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "DSD Associates Audit \u0026 Advies sc sfd sprl",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Apr\u00E8s d\u00E9lib\u00E9ration, l\u0027assembl\u00E9e des actionnaires d\u00E9cide, \u00E0 l\u0027unanimit\u00E9, de renouveler la nomination de la soci\u00E9t\u00E9 DSD Associates Audit \u0026 Advies sc sfd sprl ayant son si\u00E8ge soclal \u00E0 3391 Meensel-Kiezegem, Attenrodestraat 43 et repr\u00E9sent\u00E9e par monsieur David De Schacht, r\u00E9viseur d\u0027entreprises, pour un"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "COVANCE CLINICAL AND PERIAPPROVAL SERVICES, EN ABREGE : COVANCE CAPS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Robert James DAVIE",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2018-03-31",
      "evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e g\u00E9n\u00E9rale de la sa COVANCE CLINICAL AND PERIAPPROVAL SERVICES accepte la d\u00E9m\u00EDssion en tant qu\u0027administrateur de Monsieur Robert James DAVIE et ce avec effet au 31 mars 2018."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Glenn Andrew EISENBERG",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2018-03-31",
      "evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme en tant qu\u0027administrateur Monsieur Glenn Andrew EISENBERG,domicili\u00E9 8950 Heydon Hall Circle, Charlotte, North Carolina 28210-6058. U.S.A., Etats-Unis d\u0027Am\u00E9rique, n\u00E9 le 10 mai 1961 \u00E0 New Jersey U.S.A., de nationalit\u00E9 am\u00E9ricaine. Son mandat prend effet le 31 m"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "COVANCE CLINICAL AND PERIAPPROVAL SERVICES, EN ABREGE : COVANCE CAPS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Frederik Walter WOJTOWICZ",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2017-03-31",
      "evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e g\u00E9n\u00E9rale de la sa COVANCE CLINICAL AND PERIAPPROVAL SERVICES accepte la d\u00E9mission en tant qu\u0027administrateur de Monsieur Frederik Walter WOJTOWICZ et ce avec effet au 31 mars 2017."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Robert James DAVIE",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2017-03-31",
      "evidence_quote": "A l\u0027unanimit\u00E9, l\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme en tant qu\u0027administrateur Monsieur Robert James DAVIE, domicili\u00E9 422 Wendover Drive, Princeton, 08540 New Jersey, USA, n\u00E9 le 20 d\u00E9cembre 1959 \u00E0 Dublin, nationalit\u00E9 britannique. Son mandat prend effet le 31 mars 2017."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "COVANCE CLINICAL AND PERIAPPROVAL SERVICES, EN ABREGE : COVANCE CAPS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "David De Schacht",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "DSD Associates Audit \u0026 Advies sc sfd sprl",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Apr\u00E8s d\u00E9lib\u00E9ration, l\u0027assembl\u00E9e des actionnaires d\u00E9cide, \u00E0 l\u0027unanimit\u00E9, de renouveler la nomination de la soci\u00E9t\u00E9 DSD Associates Audit \u0026 Advies sc sfd sprl ayant son si\u00E8ge social \u00E0 3391 Tielt-Winge, Attenrodestraat 43 et repr\u00E9sent\u00E9e par monsieur David De Schacht, R\u00E9viseur d\u0027entreprises, en qualit\u00E9 d"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0435.753.395",
    "name_full": "COVANCE CLINICAL AND PERIAPPROVAL SERVICES, EN ABREGE : COVANCE CAPS",
    "legal_form": "SA"
  }
}